Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer
Clinical trial NCT00176813 · COMPLETED
Trial details
- NCT number
- NCT00176813
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-01
- Primary completion
- 2003-11-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.